This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations of Hideyuki Kato
Introduction
Hideyuki Kato is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for viral diseases. His work is characterized by a focus on creating effective and safe therapeutic agents.
Latest Patents
Kato holds a patent for a pharmaceutical composition aimed at preventing or treating viral infectious diseases. This invention is particularly noteworthy for its potent anti-HCV activity and its ability to inhibit HCV growth. The compounds developed by Kato demonstrate mild cytotoxicity in vivo, making them highly valuable as anti-HCV preventive and therapeutic agents. He has 1 patent to his name.
Career Highlights
Kato is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company in Japan. His work at Chugai has allowed him to focus on innovative solutions for combating viral infections, contributing to advancements in medical science.
Collaborations
Kato has collaborated with notable colleagues, including Miyako Masubuchi and Takuo Tsukuda. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compositions.
Conclusion
Hideyuki Kato's contributions to the field of pharmaceuticals, particularly in the area of viral disease treatment, highlight his innovative spirit and dedication to improving public health. His work continues to inspire advancements in medical research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile